Academic audit
Short Term Reversal In Stocks
Short-term reversal is the tendency for stocks that underperformed over the past month to outperform in the next, and vice versa. The classic long/short version buys recent losers and sells recent winners, rebalancing every month.
What we found
The reversal effect is real at the gross level, but it does not survive trading costs. Because the long/short book rebalances monthly, turnover is high, and the modelled costs of that turnover turn the result net negative over our sample. Risk-adjusted, the strategy came out at RF -0.7 with a worst-year RF of -0.91. This is a failed test: the underlying anomaly exists in the raw signal, but the implementation cost required to harvest it removes it.
- Data: survivorship-free 1077-name US common-stock panel, 2005-2026. Realistic modelled costs.
- Placebo / robustness test: real result vs random baskets or shuffled signals (real vs the 95th percentile of random)
Read the paper ↗
Research, not investment advice. “Validated” factor-legs are market-neutral diversifying building blocks with a losing worst year — none is a standalone tradeable strategy. Metrics are cost-aware and modelled (not live fills); the 2005–2026 test window is out-of-sample versus the source paper. Dollar figures are not returns and are omitted by design.